sprite-preloader
Anzeige
Mehr »
Freitag, 22.06.2018 Börsentäglich über 12.000 News von 586 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)
Erweiterte
Suche
lynx
Ad hoc-Mitteilungen

Aktuelle News von BioPharma-Reporter

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
MiAbSci aims to tackle the antibody market after raising $12m to scale E. coli-based tech
MiWuXi Biologics kicks off $20m ADC build in China
MiGE looks to speed drug discovery with new high capacity system
DiCellectis bakes safety switch into CAR-T to stop runaway responses
DiJefferson Institute for Bioprocessing: Site plan and launch update
15.06.IDA Ireland: Low corporate tax rate here to stay, 'difficult' to say same for US
15.06.mAb developer Oncobiologics launches CDMO business
15.06.Two US regulatory wins for Keytruda, a first for cervical cancer
14.06.Biosimilar sales remain small in 'largely untapped' market
13.06.Eisai targets dementia drug discovery with US research facility
13.06.Less-regulated markets a first stop for biosimilar development?
12.06.Parker details investment timeline, launches new single-use system
12.06.WuXi Biologics to launch in US: Tax reform makes 'investment thesis much stronger' says CEO
12.06.End of lengthy legal battle with former CRO draws near, says Cel-Sci
11.06.ADC Bio: Biotech may 'hold the key' to innovation adoption
08.06.ADC Bio: CDMOs can learn from biotechs to drive manufacturing innovation
08.06.GE grows FlexFactory presence in China with another cell therapy plant deal
06.06.Syngene teams with immuno-oncology firm to provide 'greater value-added services'
06.06.US FDA approves Cellectis' third 'off-the-shelf' CAR T-cell candidate for clinical trials
06.06.EMA recommends Pfizer's Herceptin biosimilar, EU Commission to assess
05.06.Mylan and Biocon win Neulasta race with US FDA-approved biosimilar
05.06.US FDA rejects another Herceptin biosimilar, Amgen issued CRL
01.06.CMO Rentschler signs Ultragenyx fill/finish deal for US supply
01.06.US FDA pauses CRISPR gene-edited therapy trial for sickle cell disease
01.06.Novartis invests $55m in US gene therapy site, prepares BLA